All Audiences

Sanofi to acquire Dren Bio’s bispecific myeloid cell engager for deep B-cell depletion, broadening immunology pipeline

The Future of Myeloma Treatment: What’s Next?

CAR T-Cell Therapy: A Path of Hope and Healing

banner_education_videos_necrp_12_dam_file_110701.jpg

Introducción al cáncer de la sangre: Aspectos básicos sobre la enfermedad, el tratamiento y el rol del profesional médico

Kura Oncology and Kyowa Kirin Announce Positive Ziftomenib Monotherapy Registrational Trial and Positive FDA Feedback for Upcoming Frontline Combination Trial Designs

In the Face of Uncertainty in Washington, The Leukemia & Lymphoma Society Stands with Patients

Newly FDA-approved Treatment Enhances Survival for Children and Adults with 2 Blood Cancer Types

BioInvent announces promising initial efficacy data from triple combination arm of BI-1206, rituximab and Calquence for the treatment of non-Hodgkin's lymphoma

Cafecito con LLS: Hablemos de Abogacía Legal y Atención Medica

banner-disease-info-employment-rights-of-cancer-survivors-caregivers_dam_file_12241.jpg

Histiocytic Disorders

Subscribe to All Audiences

The Leukemia & Lymphoma Society (LLS) is now Blood Cancer United. Learn more.